4-Thiazolidinones as privileged heterocycles are in focus since 60th� Main achievements are related to glitazones and set of drug-candidates with antidiabetic, antimicrobial, antiviral and anticancer activities. They are confirmed ligands toward various biotargets as well as compounds with unknown mechanism of actions� Combination of several reactive centers of main core and variety of its synthetic routs led do different 4-thiazolidinone subtypes� Among them 5-ene-thiazolidinones are of special interest due to chemical properties and pharmacological profiles. While, they are considered as frequent hitters or PAINS, which are useless because of possible low selec-tivity� This is argued by Michael acceptor property of 5-ene-4-thiazolidinones� Such thesis is discussed, and requires further investigation fol-lowing the usefulness properties of Michael ac-ceptors� The main goal of the project is the search for new 4-thiazolidinone-based drug-candidates� Methods: Drug design; synthesis; biological activity assays; SAR� Results and conclusions: The diverse in-house library have been designed and synthesized� Biological assays were focused on the search for anticancer, anti-inflammatory, antiparasitic/antimicrobial agents� Following polypharmacological approach and the multi-target drugs concept, the compound with several pharmacological effects were regarded as an advan-tage� Thus, the main directions for 4-thiazolidinones optimization were outlined: complication of C5 and modification of N3 positions; isosteric replacement; combination with other scaffolds; thiazolidinones-based synthesis of thiopyrano[2,3d]thiazoles, thiazolo[4,5-b]pyridines, isothiocoumarines, etc and "simplified" derivatives. It was shown that thiopyranothiazoles are fixed "biomimetics" of starting 5-substituted-4-thiazolidiones without Michael acceptor properties� Study of the active anticancer thiazolidinones reveled the PPAR-mediated, ROS-dependent and proapoptotic mechanisms of action� Based on the biological activity data, 4-thiazolidinones can be considered as pro-drugs with efficient character-istics� The similarity of 4-thiazolidinones with H2S donors and preliminary results open new oportunities to design of new 4-thiazolidinonebased H2S releasing agents� Additionally, Michael functionality of thiazolidinones should be used in the useful way -search for Nrf2-modulatos, covalent inhibitors, ROS modulators�
